MoneyWorks4Me

The sales moved down -36.57% to Rs. 72.74 millions for the December 2025 quarter as compared to Rs. 114.67 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2025 is Rs. -31.26 millions as compared to Net Loss of Rs. -77.39 millions of corresponding quarter ended December 2024 Operating profit Margin for the quarter ended December 2025 improved to 3.02% as compared to -44.65% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 72.74 114.67 -36.57 169.22 372.11 -54.52 433.12 504.22 -14.10
Other Income 0.04 2.51 -98.41 0.23 3.71 -93.80 7.09 4.51 57.21
PBIDT 3.02 -44.65 -106.76 -45.59 -92.52 -50.72 -143.21 -82.72 73.13
Interest 17.93 15.57 15.16 51.76 43.00 20.37 59.14 46.89 26.12
PBDT -14.91 -60.22 -75.24 -97.35 -135.52 -28.17 -202.35 -129.61 56.12
Depreciation 16.35 17.17 -4.78 48.58 51.19 -5.10 66.89 67.66 -1.14
PBT -31.26 -77.39 -59.61 -145.93 -186.71 -21.84 -269.24 -197.27 36.48
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -31.26 -77.39 -59.61 -145.93 -186.71 -21.84 -269.39 -197.27 36.56
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) 4.15 -38.94 -110.66 -26.94 -24.86 8.36 -33.06 -16.41 101.55
Peers
Company Name CMP
Sun Pharma. Inds. 1862.00
Dr. Reddys Labs. 1210.70
Cipla 1407.70
Lupin 2111.90
Zydus Lifesciences 1179.50
View more..